Eduardo L. Setti - Concepedia

Author

Eduardo L. Setti

Consejo Nacional de Investigaciones Científicas y Técnicas

Also Known As

E L Setti, E. L. SETTI, E.L. Setti, Eduardo L Setti, Eduardo L. Setti, Eduardo Setti, Setti

Publications

533

Citations

H-Index

Concepts

All Affiliations

Consejo Nacional de Investigaciones Científicas y Técnicas Bristol-Myers Squibb (Switzerland)Merck & Co., Inc., Rahway, NJ, USA (United States)Brandywine Photonics (United States)

About

Eduardo L. Setti is an author at Consejo Nacional de Investigaciones Científicas y Técnicas specializing in pharmacology, medicinal chemistry, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	11	422
2	Natural Sciences	9	9	343
3	Biochemistry	6	6	301
4	Engineering	2	2	24
5	Biomolecular Engineering	1	1	10

Eduardo L. Setti

Publications

482

Citations

H-Index

Page 1

	Year	Citations
Design and Synthesis of Tri-Ring P<sub>3</sub> Benzamide-Containing Aminonitriles as Potent, Selective, Orally Effective Inhibitors of Cathepsin K James T. Palmer, Clifford Bryant, Dan-Xiong Wang, Journal of Medicinal Chemistry Pharmaceutical ScienceSclerostinBone ResorptionOrganic ChemistryPharmacotherapy	2005	94
A Novel Class of Nonpeptidic Biaryl Inhibitors of Human Cathepsin K Joël Robichaud, Renata M. Oballa, Peppi Prasit, Journal of Medicinal Chemistry SclerostinBioorganic ChemistryHuman Cathepsin KPharmacotherapyChemical Biology	2003	82
Identification of 1-(3-(6,7-Dimethoxyquinazolin-4-yloxy)phenyl)-3-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)urea Hydrochloride (CEP-32496), a Highly Potent and Orally Efficacious Inhibitor of V-RAF Murine Sarcoma Viral Oncogene Homologue B1 (BRAF) V600E Martin W. Rowbottom, Raffaella Faraoni, Qi Chao, Journal of Medicinal Chemistry Orally Efficacious InhibitorChemoprevention StrategyImmunologySeveral BrafAntiviral Drug	2011	58
3,4-Disubstituted azetidinones as selective inhibitors of the cysteine protease cathepsin K. Exploring P2 elements for selectivity Eduardo L. Setti, Dana Davis, Tobee Chung, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyBiochemistryMedicineNatural SciencesRational Drug Design	2003	56
β-Substituted Cyclohexanecarboxamide: A Nonpeptidic Framework for the Design of Potent Inhibitors of Cathepsin K Sheldon N. Crane, W. Cameron Black, James T. Palmer, Journal of Medicinal Chemistry	2006	36
3,4-Disubstituted azetidinones as selective inhibitors of the cysteine protease cathepsin K. Exploring P3 elements for potency and selectivity Eduardo L. Setti, Dana Davis, James W. Janc, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyMedicinal ChemistryBiochemistryMedicineNatural Sciences	2005	29
Stereoselective synthesis of 6-fluoropenicillanate analogs of .beta.-lactamase inhibitors Ernesto G. Mata, Eduardo L. Setti, Oreste A. Mascaretti The Journal of Organic Chemistry Medicinal ChemistryAntimicrobial Drug DiscoveryPharmaceutical ScienceMedicineRational Drug Design	1990	21
Recent advances in the chemistry of beta-lactam compounds as selected active-site serine beta-lactamase inhibitors. Oreste A. Mascaretti, Gerardo O. Danelón, Marı́a Laborde, PubMed Crystal StructurePharmacotherapyChemical BiologyPharmaceutical ChemistryB-lactam Bond	1999	20
Recent Advances in the Chemistry of β-Lactam Compounds as Selected Active-site Serine β-Lactamase Inhibitors Oreste A. Mascaretti, Gerardo O. Danelón, Eduardo L. Setti, Current Pharmaceutical Design β-Lactam CompoundsCrystal StructureAntimicrobial ChemotherapyPharmaceutical ChemistryMolecular Pharmacology	1999	20
Synthesis of (pivaloyloxy)methyl 6α-fluoropenicillanate Eduardo L. Setti, Oreste A. Mascaretti Journal of the Chemical Society Perkin Transactions 1 Bioorganic ChemistryDerivativesPorm 6β-AminopenicillanateNatural SciencesMedicine	1988	19

Page 1